Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma

Autor: Başoğlu T; Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey, Akar KE; Department of Pathology, Marmara University School of Medicine, İstanbul, Turkey, Bağcı P; Department of Pathology, Marmara University School of Medicine, İstanbul, Turkey, Akgül Babacan N; Department of Medical Oncology, Bahrain Oncology Center, Al Sayh, Bahrain, Öztürk MA; Department of Medical Oncology, Bahçeşehir University School of Medicine, İstanbul, Turkey, Öztürk FE; Department of Internal Medicine, Marmara University School of Medicine, İstanbul, Turkey, Demircan NC; Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey, Arikan R; Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey, Akın Telli T; Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey, Ercelep Ö; Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey, Dane F; Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey, Yumuk PF; Department of Medical Oncology, Marmara University School of Medicine, İstanbul, Turkey
Jazyk: angličtina
Zdroj: Balkan medical journal [Balkan Med J] 2022 Jan 25; Vol. 39 (1), pp. 12-20. Date of Electronic Publication: 2021 Dec 20.
DOI: 10.5152/balkanmedj.2021.21122
Abstrakt: Background: Pancreatic ductal adenocarcinoma differs from other solid tumors with its unique immunosuppressive microenvironment and non-immunogenic feature. There are not many studies in the literature investigating the effect of these features on prognosis.
Aims: To investigate the prognostic value of tissue-resident memory T cells, tumor microenvironment features, and tumor-associated immune cells in resected pancreatic ductal adenocarcinomas.
Study Design: Retrospective cross-sectional study.
Methods: Of 138 patients diagnosed with pancreatic ductal adenocarcinoma between 2011 and 2018, 81 were included in the study. Specimens from operated patients were reassessed separately as peritumoral and intratumoral areas for tissue resident memory cells and tumor microenvironmental elements (tumor infiltrating lymphocytes, tumor stroma, CD204+ macrophages, PDL1+ immune cells). Disease-free survival and overall survival were defined from the date of operation to the date of recurrence and the date of first diagnosis to the date of death, respectively. If the patient was alive, the last visit date was taken into account.
Results: The median age at diagnosis was 63 (range: 40-78). The median follow-up period was 18.9 months (range: 1.4-80.4 months). Median overall survival was 23.7 months (1.4-80.4 months) and median disease-free survival was 10.8 months (1.4-74.4 months). Patients with higher intra-tumoral tissue-resident memory cell counts had a longer survival trend than those having lower values (25.6 months vs. 18 months, respectively, P = .84). According to microenvironmental evaluations, lower stromal score (defined as stroma having less desmoplasia and rich in cells) and presence of peritumoral Crohn’s-like inflammatory response were associated with higher survival (29.2 months vs. 19.7 months for low vs. high stromal scores, respectively, P = .16 and 30.2 months vs. 18.1 months for the presence of Crohn’s-like inflammatory response P = .13). Decreased survival was observed in tumors with increased CD204+ tumor-associated macrophages which were immunosuppressive elements of the microenvironment (12 months vs. 26.3 months for intra-tumoral assessment, P = .29).
Conclusion: Tissue-resident memory T cells and other microenvironmental features may be prognostic in resectable pancreatic ductal adenocarcinomas. Further studies with larger cohorts are needed for validation.
Databáze: MEDLINE
Externí odkaz: